Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tetracaine 0.5% eye drops 0.5ml unit dose preservative free
1107000C0AAADAD
|
Tetracaine hydrochloride (Eye) | Tetracaine hydrochloride | Eye | 27 |
|
Tetracaine 1% eye drops 0.5ml unit dose preservative free
1107000C0AAAEAE
|
Tetracaine hydrochloride (Eye) | Tetracaine hydrochloride | Eye | 17 |
|
Minims tetracaine hydrochloride 0.5% eye dps 0.5ml unit dose
1107000C0BBAAAD
|
Minims tetracaine hydrochloride | Tetracaine hydrochloride | Eye | 2 |
|
Minims tetracaine hydrochloride 1% eye drops 0.5ml unit dose
1107000C0BBABAE
|
Minims tetracaine hydrochloride | Tetracaine hydrochloride | Eye | 2 |
|
Anethaine 1% cream
1303000A0BBAAAB
|
Anethaine | Tetracaine hydrochloride | Skin | No data available |
|
Chlorhexidine 0.05% / Tetracaine 0.015% oromucosal spy SF
1203030G0AAAAAA
|
Chlorhexidine gluconate/tetracaine hydrochloride | Tetracaine hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Eludril spray
1203030G0BBAAAA
|
Eludril (Spray) | Tetracaine hydrochloride | Ear, Nose and Oropharynx | No data available |
|
Tetracaine 1% cream
1303000A0AAABAB
|
Tetracaine hydrochloride (Topical) | Tetracaine hydrochloride | Skin | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.